Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: a systematic review and meta-analysis

Author:

Pavlov Ivan1ORCID,He Hangyong2,McNicholas Bairbre3,Perez Yonatan4,Tavernier Elsa4,Trump Matthew W.5,Jackson Julie A.6,Zhang Wei7,Rubin Daniel S.8,Spiegel Thomas8,Hung Anthony8,Estrada Miguel Ángel Ibarra9,Roca Oriol10,Vines David L.11,Cosgrave David3,Mirza Sara11,Laffey John G.3,Rice Todd W.12,Ehrmann Stephan4,Li Jie13ORCID

Affiliation:

1. CH Verdun: Centre Hospitalier de Verdun

2. Capital Medical University

3. NUI Galway: National University of Ireland Galway

4. CHRU Tours: Centre Hospitalier Regional Universitaire de Tours

5. The Iowa Clinic

6. UnityPoint Health

7. Second Military Medical University First Hospital: Changhai Hospital

8. UChicago Medicine

9. Civil Hospital of Guadalajara: Hospital Civil de Guadalajara

10. Vall d'Hebron Hospital: Vall d'Hebron Hospital Universitari

11. Rush University

12. Vanderbilt University Medical Center

13. Rush University Medical Center

Abstract

Abstract Background: Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review and meta-analysis of observational studies to compare oxygenation parameters in-hospital intubation rate in patients treated with APP or with standard care.Results: A total of 46 published and 4 unpublished observational studies that included 2994 patients were included. APP was associated with significant improvement of various oxygenation parameters in 19 studies (n=381) that reported this outcome. The intubation rate was 27% (95%CI, 19 to 37%) in the 870 patients treated with APP, as compared to 30% (95%CI, 20 to 42%) in the 852 patients treated with usual care (p=0.71).Conclusions: On the basis of the available evidence, it is not possible to demonstrate efficacy of APP for patients with COVID-19 acute respiratory failure, as assessed by the need for invasive ventilation. Routine implementation of APP outside of a clinical trial is not supported by current evidence. Randomized controlled clinical studies are urgently needed to definitively assess the utility of APP in these patients.Registered on PROSPERO on August 3d, 2020, CRD42020201947.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3